BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31118101)

  • 1. Remote ischemic conditioning in septic shock (RECO-Sepsis): study protocol for a randomized controlled trial.
    Cour M; Buisson M; Klouche K; Bouzgarrou R; Schwebel C; Quenot JP; Zeni F; Beuret P; Ovize M; Argaud L
    Trials; 2019 May; 20(1):281. PubMed ID: 31118101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remote ischemic conditioning in septic shock: the RECO-Sepsis randomized clinical trial.
    Cour M; Klouche K; Souweine B; Quenot JP; Schwebel C; Perinel S; Amaz C; Buisson M; Ovize M; Mewton N; Argaud L;
    Intensive Care Med; 2022 Nov; 48(11):1563-1572. PubMed ID: 36100725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EXCHANGE-2: investigating the efficacy of add-on plasma exchange as an adjunctive strategy against septic shock-a study protocol for a randomized, prospective, multicenter, open-label, controlled, parallel-group trial.
    David S; Bode C; Stahl K;
    Trials; 2023 Apr; 24(1):277. PubMed ID: 37061693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remote ischemic conditioning in ST-elevation myocardial infarction as adjuvant to primary angioplasty (RIC-STEMI): study protocol for a randomized controlled trial.
    Gaspar A; Pereira MÁ; Azevedo P; Lourenço A; Marques J; Leite-Moreira A
    Trials; 2015 Sep; 16():398. PubMed ID: 26350480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The scientific rationale and study protocol for the DPP3, Angiotensin II, and Renin Kinetics in Sepsis (DARK-Sepsis) randomized controlled trial: serum biomarkers to predict response to angiotensin II versus standard-of-care vasopressor therapy in the treatment of septic shock.
    Teixeira JP; Perez Ingles D; Barton JB; Dean JT; Garcia P; Kunkel SJ; Sarangarm P; Weiss NK; Schaich CL; Busse LW; Nielsen ND
    Trials; 2024 Mar; 25(1):182. PubMed ID: 38475822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial.
    Soto A; Krapp F; Vargas A; Cabrejos L; Argumanis E; García PL; Altamirano K; Montes M; Chacón-Uscamaita PR; García PJ
    Trials; 2021 May; 22(1):342. PubMed ID: 34001174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive use of physostigmine salicylate (Anticholium®) in perioperative sepsis and septic shock: study protocol for a randomized, double-blind, placebo-controlled, monocentric trial (Anticholium® per Se).
    Zimmermann JB; Pinder N; Bruckner T; Lehmann M; Motsch J; Brenner T; Hoppe-Tichy T; Swoboda S; Weigand MA; Hofer S
    Trials; 2017 Nov; 18(1):530. PubMed ID: 29126416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
    Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
    Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of iloprost in patients with septic shock-induced endotheliopathy-Protocol for the multicenter randomized, placebo-controlled, blinded, investigator-initiated trial.
    Bestle MH; Clausen NE; Søe-Jensen P; Kristiansen KT; Lange T; Johansson PI; Stensballe J; Perner A
    Acta Anaesthesiol Scand; 2020 May; 64(5):705-711. PubMed ID: 31950481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An efficacy and mechanism evaluation study of Levosimendan for the Prevention of Acute oRgan Dysfunction in Sepsis (LeoPARDS): protocol for a randomized controlled trial.
    Orme RM; Perkins GD; McAuley DF; Liu KD; Mason AJ; Morelli A; Singer M; Ashby D; Gordon AC
    Trials; 2014 Jun; 15():199. PubMed ID: 24894386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Ascorbic Acid, Corticosteroids, and Thiamine on Organ Injury in Septic Shock: The ACTS Randomized Clinical Trial.
    Moskowitz A; Huang DT; Hou PC; Gong J; Doshi PB; Grossestreuer AV; Andersen LW; Ngo L; Sherwin RL; Berg KM; Chase M; Cocchi MN; McCannon JB; Hershey M; Hilewitz A; Korotun M; Becker LB; Otero RM; Uduman J; Sen A; Donnino MW;
    JAMA; 2020 Aug; 324(7):642-650. PubMed ID: 32809003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The I-MICRO trial, Ilomedin for treatment of septic shock with persistent microperfusion defects: a double-blind, randomized controlled trial-study protocol for a randomized controlled trial.
    Legrand M; Oufella HA; De Backer D; Duranteau J; Leone M; Levy B; Rossignol P; Vicaut E; Dépret F;
    Trials; 2020 Jul; 21(1):601. PubMed ID: 32611377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enteral citrulline supplementation versus placebo on SOFA score on day 7 in mechanically ventilated critically ill patients: the IMMUNOCITRE randomized clinical trial.
    Tadié JM; Locher C; Maamar A; Reignier J; Asfar P; Commereuc M; Lesouhaitier M; Gregoire M; Le Pabic E; Bendavid C; Moreau C; Diehl JL; Gey A; Tartour E; Le Tulzo Y; Thibault R; Terzi N; Gacouin A; Roussel M; Delclaux C; Tarte K; Cynober L
    Crit Care; 2023 Oct; 27(1):381. PubMed ID: 37784110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Landiolol and Organ Failure in Patients With Septic Shock: The STRESS-L Randomized Clinical Trial.
    Whitehouse T; Hossain A; Perkins GD; Gordon AC; Bion J; Young D; McAuley D; Singer M; Lord J; Gates S; Veenith T; MacCallum NS; Yeung J; Innes R; Welters I; Boota N; Skilton E; Ghuman B; Hill M; Regan SE; Mistry D; Lall R;
    JAMA; 2023 Nov; 330(17):1641-1652. PubMed ID: 37877587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shock-1 (AdrenOSS-1) study.
    Mebazaa A; Geven C; Hollinger A; Wittebole X; Chousterman BG; Blet A; Gayat E; Hartmann O; Scigalla P; Struck J; Bergmann A; Antonelli M; Beishuizen A; Constantin JM; Damoisel C; Deye N; Di Somma S; Dugernier T; François B; Gaudry S; Huberlant V; Lascarrou JB; Marx G; Mercier E; Oueslati H; Pickkers P; Sonneville R; Legrand M; Laterre PF;
    Crit Care; 2018 Dec; 22(1):354. PubMed ID: 30583748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy of vitamin C and thiamine for septic shock in a multicentre, double-blind, randomized, controlled study (ATESS): study protocol for a randomized controlled trial.
    Hwang SY; Park JE; Jo IJ; Kim S; Chung SP; Kong T; Shin J; Lee HJ; You KM; Jo YH; Kim D; Suh GJ; Kim T; Kim WY; Kim YJ; Ryoo SM; Choi SH; Shin TG;
    Trials; 2019 Jul; 20(1):420. PubMed ID: 31296251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock: The ANDROMEDA-SHOCK Randomized Clinical Trial.
    Hernández G; Ospina-Tascón GA; Damiani LP; Estenssoro E; Dubin A; Hurtado J; Friedman G; Castro R; Alegría L; Teboul JL; Cecconi M; Ferri G; Jibaja M; Pairumani R; Fernández P; Barahona D; Granda-Luna V; Cavalcanti AB; Bakker J; ; Hernández G; Ospina-Tascón G; Petri Damiani L; Estenssoro E; Dubin A; Hurtado J; Friedman G; Castro R; Alegría L; Teboul JL; Cecconi M; Cecconi M; Ferri G; Jibaja M; Pairumani R; Fernández P; Barahona D; Cavalcanti AB; Bakker J; Hernández G; Alegría L; Ferri G; Rodriguez N; Holger P; Soto N; Pozo M; Bakker J; Cook D; Vincent JL; Rhodes A; Kavanagh BP; Dellinger P; Rietdijk W; Carpio D; Pavéz N; Henriquez E; Bravo S; Valenzuela ED; Vera M; Dreyse J; Oviedo V; Cid MA; Larroulet M; Petruska E; Sarabia C; Gallardo D; Sanchez JE; González H; Arancibia JM; Muñoz A; Ramirez G; Aravena F; Aquevedo A; Zambrano F; Bozinovic M; Valle F; Ramirez M; Rossel V; Muñoz P; Ceballos C; Esveile C; Carmona C; Candia E; Mendoza D; Sanchez A; Ponce D; Ponce D; Lastra J; Nahuelpán B; Fasce F; Luengo C; Medel N; Cortés C; Campassi L; Rubatto P; Horna N; Furche M; Pendino JC; Bettini L; Lovesio C; González MC; Rodruguez J; Canales H; Caminos F; Galletti C; Minoldo E; Aramburu MJ; Olmos D; Nin N; Tenzi J; Quiroga C; Lacuesta P; Gaudín A; Pais R; Silvestre A; Olivera G; Rieppi G; Berrutti D; Ochoa M; Cobos P; Vintimilla F; Ramirez V; Tobar M; García F; Picoita F; Remache N; Granda V; Paredes F; Barzallo E; Garcés P; Guerrero F; Salazar S; Torres G; Tana C; Calahorrano J; Solis F; Torres P; Herrera L; Ornes A; Peréz V; Delgado G; López A; Espinosa E; Moreira J; Salcedo B; Villacres I; Suing J; Lopez M; Gomez L; Toctaquiza G; Cadena Zapata M; Orazabal MA; Pardo Espejo R; Jimenez J; Calderón A; Paredes G; Barberán JL; Moya T; Atehortua H; Sabogal R; Ortiz G; Lara A; Sanchez F; Hernán Portilla A; Dávila H; Mora JA; Calderón LE; Alvarez I; Escobar E; Bejarano A; Bustamante LA; Aldana JL
    JAMA; 2019 Feb; 321(7):654-664. PubMed ID: 30772908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.